Testofen, a specialised Trigonella foenum-graecum seed extract reduces age-related symptoms of androgen decrease, increases testosterone levels and improves sexual function in healthy aging males in a double-blind randomised clinical study

References

• Morley JE, Kaiser FE, Perry HM III, et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metab Clin Exp 1997;46:410–13.
   PubMed Web of Science ®Google Scholar
• Matsumoto AM. Andropause: Clinical implications of the decline in serum testosterone level with aging in men. J Gerontol a Biol Sci Med Sci 2002;57:76–99.
   PubMed Web of Science ®Google Scholar
• Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 2002;87:589–98.
   PubMed Web of Science ®Google Scholar
• Sartorius G, Spasevska S, Idan A, et al. Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study. Clin Endocrinol (Oxf). 2012;77:755–63.
   PubMed Web of Science ®Google Scholar
• Camacho EM1, Huhtaniemi IT, O'Neill TW, et al. EMAS Group. Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. Eur J Endocrinol. 2013 Feb 20;168:445–55.
   PubMed Web of Science ®Google Scholar
• Shi Z, Araujo AB, Martin S, et al. Longitudinal changes in testosterone over five years in community-dwelling men. J Clin Endocrinol Metab. 2013 Aug;98:3289–97.
   PubMed Web of Science ®Google Scholar
• Keenan DM, Takahashi PY, Liu PY, et al. An ensemble model of the male gonadal axis: illustrative application in aging men. Endocrinology 2006;147:2817–28.
   PubMed Web of Science ®Google Scholar
• Golan R, Scovell JM, Ramasamy R. Age-related testosterone decline is due to waning of both testicular and hypothalamic-pituitary function. Aging Male. 2015;18:201–4.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Tolrà J, Torremadé Barreda J, del Rio L, et al. Effects of testosterone treatment on body composition in males with testosterone deficiency syndrome. Aging Male 2013;16:184–90.
   PubMed Web of Science ®Google Scholar
• Yeap BB1, Araujo AB, Wittert GA. Do low testosterone levels contribute to ill-health during male ageing? Crit Rev Clin Lab Sci. 2012;49:168–82.
   PubMed Web of Science ®Google Scholar
• Hsu B, Cumming RG, Blyth FM, et al. The longitudinal relationship of sexual function and androgen status in older men: the concord health and ageing in men project. J Clin Endocrinol Metab 2015;100:1350–8.
   PubMed Web of Science ®Google Scholar
• Antonio L, Wu FC, O'Neill TW, et al. EMAS Study Group. Associations between sex steroids and the development of metabolic syndrome: a longitudinal study in European men. J Clin Endocrinol Metab 2015;100:1396–404.
   PubMed Web of Science ®Google Scholar
• Hsu B, Cumming RG, Waite LM, et al. Longitudinal relationships between reproductive hormones and cognitive decline in older men: the concord health and ageing in men project. J Clin Endocrinol Metab 2015;100:2223–30.
   PubMed Web of Science ®Google Scholar
• Zitzmann M. Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol 2009;5:673–81.
   PubMed Web of Science ®Google Scholar
• Behre M, Tammela T, Arver S, et al. A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up. Aging Male 2012;15:198–207.
   PubMed Web of Science ®Google Scholar
• Khaw KT, Dowsett M, Folkerd E, et al. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 2007;116:2694–701.
   PubMed Web of Science ®Google Scholar
• Laaksonen DE, Niskanen L, Punnonen K, et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 2004;27:1036–41.
   PubMed Web of Science ®Google Scholar
• Cicero TJ. Effects of exogenous and endogenous opiates on the hypothalamic-pituitary-gonadal axis in the male. Fed Proc 1980;39:2551–4.
   PubMedGoogle Scholar
• Elliott JA, Opper SE, Agarwal S, Fibuch EE. Non-analgesic effects of opioids: opioids and the endocrine system. Curr Pharm Des 2012;18:6070–8.
   PubMed Web of Science ®Google Scholar
• Corssmit EP, Endert E, Sauerwein HP, Romijn JA. Acute effects of interferon-alpha administration on testosterone concentrations in healthy men. Eur J Endocrinol 2000;143:371–4.
   PubMed Web of Science ®Google Scholar
• Singh P. Andropause: current concepts. Indian J Endocrinol Metab 2013;17:621–9.
   PubMedGoogle Scholar
• Ullah MI, Riche DM, Koch CA. Transdermal testosterone replacement therapy in men. Drug Design Dev Therapy 2014;8:101–12.
   PubMed Web of Science ®Google Scholar
• Liu PY, Beilin J, Meier C, et al. Age-related changes in serum testosterone and sex hormone binding globulin in Australian men: longitudinal analyses of two geographically separate regional cohorts. J Clin Endocrinol Metab 2007;92:3599–603.
   PubMed Web of Science ®Google Scholar
• Wu FC, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 2010;363:123–35.
   PubMed Web of Science ®Google Scholar
• Mulligan T, Frick MF, Zuraw QC, et al. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract 2006;60:762–9.
   PubMed Web of Science ®Google Scholar
• Miner M, Canty DJ, Shabsigh R. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices. Postgrad Med 2008;120:130–53.
   PubMed Web of Science ®Google Scholar
• LeBlanc ES, Wang PY, Lee CG, et al. Higher testosterone levels are associated with less loss of lean body mass in older men. J Clin Endocrinol Metab 2011;96:3855–63.
   PubMed Web of Science ®Google Scholar
• Auyeung TW, Lee JS, Kwok T, et al. Testosterone but not estradiol level is positively related to muscle strength and physical performance independent of muscle mass: a cross-sectional study in 1489 older men. Eur J Endocrinol 2011;164:811–17.
   PubMed Web of Science ®Google Scholar
• Gooren LJ. Androgens and male aging: current evidence of safety and efficacy. Asian J Androl 2010;12:136–51.
   PubMed Web of Science ®Google Scholar
• Srinivas-Shankar U, Roberts SA, Connolly MJ, et al. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2010;95:639–50.
   PubMed Web of Science ®Google Scholar
• Steels E, Rao A, Vitetta L. Physiological aspects of male libido enhanced by standardized Trigonella foenum-graecum extract and mineral formulation. Phytotherapy Res 2011;25:1294–300.
   PubMed Web of Science ®Google Scholar
• Wankhede S, Mohan V, Thakurdesai P. Beneficial effects of fenugreek glycoside supplementation in male subjects during resistance training: a randomized controlled pilot study. J Sport and Health Sci 2015; ‘in press.’
   PubMedGoogle Scholar
• Price KR, Johnson IT, Fenwick GR. The chemistry and biological significance of saponins in foods and feedingstuffs. Crit Rev Food Sci Nutr 1987;26:27–135.
   PubMed Web of Science ®Google Scholar
• Aswar U, Bodhankar SL, Mohan V, Thakurdesai PA. Effect of furostanol glycosides from Trigonella foenum-graecum on the reproductive system of male albino rats. Phytother Res 2010;24:1482–8.
   PubMed Web of Science ®Google Scholar
• Wilborn C, Taylor L, Poole C, et al. Effects of a purported aromatase and 5 a-reductase inhibitor on hormone profiles in college-age man. Int J Sport Nutr Exe 2010;20:457–65.
   PubMed Web of Science ®Google Scholar
• Daig I, Heinemann LAJ, Kim S, et al. The Aging Males Symptoms (AMS) scale: review of its methodological characteristics. Health Quality Life Outcomes 2003;1:77.
   PubMedGoogle Scholar
• Derogatis LR, Mellisaratos N. The DSFI: a multidimensional measure of sexual functioning. J Sex Marital Ther 1979;5:244–81.
   PubMed Web of Science ®Google Scholar
• Sodergad R, Backstrom T, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 1982;16:801–10.
   PubMedGoogle Scholar
• Buysse DJ, Reynolds CF, Monk TH, et al. The Pittsburgh Sleep Quality Index (PSQI): a new instrument for psychiatric research and practice. Psychiatry Res 1989;28:193–213.
   PubMed Web of Science ®Google Scholar
• Stein KD, Martin SC, Hann DM, Jacobsen PB. A multidimensional measure of fatigue for use with cancer patients. Cancer Pract 1998;6:143–52.
   PubMedGoogle Scholar
• Craig CL, Marshall AL, Sjostrom A, et al. International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381–95.
   PubMed Web of Science ®Google Scholar
• Heinemann LAJ, Zimmermann T, Vermeulen A, et al. A new ‘Aging Males’ symptoms’ rating scale. Aging Male 1999;2:105–14.
   Google Scholar
• Travison TG, Morley JE, Araujo AB, et al. The relationship between libido and testosterone levels in aging men. J Clin Endocrinol Metab 2006;91:2509–13.
   PubMed Web of Science ®Google Scholar
• Morley JE, Perry HM, III Kevorkian RT, Patrick P. Comparison of screening questionnaires for the diagnosis of hypogonadism. Maturitas 2006;53:424–9.
   PubMed Web of Science ®Google Scholar
• Clapauch R, Braga DJ, Marinheiro LP, et al. Risk of late-onset hypogonadism (andropause) in Brazilian men over 50 years of age with osteoporosis: usefulness of screening questionnaires. Arq Bras Endocrinol Metabol 2008;52:1439–47.
   PubMed Web of Science ®Google Scholar
• Miwa Y, Kaneda T, Yokoyama O. Correlation between the Aging Males’ Symptoms Scale and sex steroids, gonadotropins, dehydroepiandrosterone sulfate, and growth hormone levels in ambulatory men. J Sex Med 2006;3:723–6.
   PubMed Web of Science ®Google Scholar
• Kang J, II Ham BK, Oh MM, et al. Correlation between serum total testosterone and the AMS and IIEF questionnaires in patients with erectile dysfunction with testosterone deficiency syndrome. Korean J Urol 2011;52:416–20.
   PubMedGoogle Scholar
• Zengerling F, Schrader A, Cronauer M, et al. The Aging Males' Symptoms’ Scale (AMS): predictive value for lowered circulating androgens. Aging Male 2012;15:253–7.
   PubMed Web of Science ®Google Scholar
• DeFina LF, Radford NB, Leonard D, et al. MON-0012: testosterone level in men is lower with increasing BMI and decreasing cardiorespiratory fitness but is not related to age. Endocrine Society's 96th Annual Meeting and Expo, 21–24 June 2014, Chicago.
   Google Scholar
• Huhtaniemi I. Late-onset hypogonadism: current concepts and controversies of pathogenesis, diagnosis and treatment. Asian J Androl 2014;16:192–202.
   PubMed Web of Science ®Google Scholar
• Correa L, Rombaldi AJ, da Silva MC. Physical activity and aging male symptoms in a southern Brazilian population. Rev Bras Med Esporte 2011;17:228–31.
   Web of Science ®Google Scholar
• Beutel ME, Wiltink J, Hauck EW, et al. Correlations between hormones, physical, and affective parameters in aging urologic outpatients. Eur Urol 2005;47:749–55.
   PubMed Web of Science ®Google Scholar
• Pexman-Fieth C, Behre HM, Morales A, et al. A 6-month observational study of energy, sexual desire, and body proportions in hypogonadal men treated with a testosterone 1% gel. Aging Male 2014;17:1–11.
   PubMed Web of Science ®Google Scholar
• Lunenfeld B, Mskhalaya G, Zitzmann M, et al. Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. The Aging Male 2015;18:5–15.
   PubMed Web of Science ®Google Scholar